Evaluation of systematic and random factors in measurements of fasting plasma glucose as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 3, 2001, Pages 191-204

  Hyltoft Petersen, P ^a   Brandslund, I ^a   Jorgensen L ^a   Stahl, M ^a   De Fine Olivarius, F ^a   Borch Johnsen, K ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Analysis of clinical setting; Analytical bias; Analytical errors; Analytical imprecision; Clinical outcome; Diabetes mellitus; Diagnostic criteria; Fasting plasma glucose; Pre analytical factors

Indexed keywords

GLUCOSE;

ANALYTICAL ERROR; ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

BLOOD GLUCOSE; CHEMISTRY, CLINICAL; DIABETES MELLITUS, TYPE 2; FASTING; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SOCIETIES, MEDICAL; SPECIMEN HANDLING; WORLD HEALTH ORGANIZATION;

EID: 0035002473     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655101300133630     Document Type: Article

References (33)

1. The report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Quality assessment of blood glucose testing in general practitioners' offices improves quality
3. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendation on diagnosis of diabetes mellitus
4. The plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendation on diagnosis of diabetes mellitus
5. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. III. Physiological and medical implications
6. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry
7. Desirable routine analytical goals for quantities assayed in serum. Discussion paper from the members of the external quality assessment (EQA) working group A on analytical goals in laboratory medicine
8. Medical need for quality specifications in clinical laboratories
9. Strategies to set global analytical quality specifications in laboratory medicine
10. Optimum screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis
11. Analytical quality specifications for serum lactate dehydrogenase isoenzyme 1 based on clinical goals
12. A conceptual model for establishing tolerance limits for analytical bias and imprecision based on variations in population test distributions
13. Clinical assessment of haemoglobin values by general practitioners related to analytical and biological variation
14. Quality specifications based on analysis of effects of performance on clinical decision-making
15. Proposals for setting generally applicable quality goals solely based on biology
16. Effects of intra- and inter-individual variation on the appropriate use of normal ranges
17. Intra- and inter-individual biological variability data bank
18. Current databases on biological variation: Pros, cons and progress
19. Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance tests
20. Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots
21. Clinical test evaluation. Unimodal and bimodal approaches
22. Ways of assessing quality goals for diagnostic tests in clinical situations
23. Influence of analytical quality on test results
24. Quality-control (QC) performance measures and the QC-planning process
25. Analytical performance characteristics should be judged against objective quality specifications
26. Consensus agreement
27. Laboratory process specifications for assuring quality in the US national cholesterol education program
28. Effect of changing diagnostic criteria on the risk of developing diabetes
29. Diagnostic criteria for diabetes mellitus